300702SZSE

Tianjian Certified Public Accountants (Special General Partnership) Report on Internal Control Audit of Zhejiang Tianyu Pharmaceutical Co., Ltd. Tianjian Audit [2026] No. 9238

Zhejiang Tianyu Pharmaceutical Co., Ltd.··3 pages

✨ AI Summary

This report presents the internal control audit findings for Zhejiang Tianyu Pharmaceutical Co., Ltd. as of December 31, 2025. The auditors conclude that the company's financial reporting internal controls were effective in all material respects. The report also outlines the responsibilities of both the company and the auditors regarding internal controls.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Table of Contents

One. Report on Internal Control Audit..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing